Marcus Jones
Main Page: Marcus Jones (Conservative - Nuneaton)Department Debates - View all Marcus Jones's debates with the Department for Education
(9 years, 1 month ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Nick Boles
I am not denying anything, but the Opposition seem incapable of recognising that, first, this Government have created more jobs than any Government in the entire European Union, so many of the adults that the hon. Gentleman is talking about are now in work and happily so, and secondly, that we have invested more money in apprenticeships, and apprenticeships are the best and most productive form of training. I note that his college’s performance on apprenticeships is woeful and is declining at a time when we are offering colleges more money every year to help adults also into apprenticeships.
Mr Marcus Jones (Nuneaton) (Con)
Recently, Georgie Hall, my 23-month-old constituent, lost her short fight against meningitis. Her parents Matt and Paula Hall are understandably devastated. Given the impasse over the meningitis B vaccine, can my hon. Friend the life sciences Minister use his best offices to resolve the issue between GlaxoSmithKline and the Government? Will he consider looking at a new framework for drug procurement to avoid this type of impasse and future tragedies like the one that the Hall family has suffered?
The Parliamentary Under-Secretary of State for Business, Innovation and Skills (George Freeman)
I pay tribute to my hon. Friend’s work on this issue, which he has raised with me on more than one occasion. I am sure the whole House will want to join me in passing on our condolences to Matt and Paula Hall for the loss of their daughter Georgie from this terrible bacterial disease.
I can confirm that I have asked the Joint Committee on Vaccination and Immunisation for recommendations on a national immunisation programme and will use my offices in the Department of Health as well as the Department for Business, Innovation and Skills to drive negotiations with the company on a fair price. It is also right to point out that we have launched an accelerated access programme for the quicker adoption of innovative medicines in the NHS, which will also help.